Adjunctive Pimavanserin in Patients with Major Depressive Disorder: Combined Results from Two Randomized, Double-Blind, Placebo-Controlled Phase 3 Studies

Authors

Institutions

Publication Details

Journal
Psychopharmacology Bulletin
Published
2025-08-12
DOI
https://doi.org/10.64719/pb.4448
Citations
6
Primary Topic
Tryptophan and brain disorders
Type
article
Field-Weighted Citation Impact
1.73
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Adjunctive Pimavanserin in Patients with Major Depressive Disorder: Combined Results from Two Randomized, Double-Blind, Placebo-Controlled Phase 3 Studies

Becky Howell, Bryan Dirks, S. Stankovic, Maurizio Fava et al.
6 citations
Psychopharmacology Bulletin
Tryptophan and brain disorders
1.73
article

Adjunctive Pimavanserin in Patients with Major Depressive Disorder: Combined Results from Two Randomized, Double-Blind, Placebo-Controlled Phase 3 Studies

Becky Howell, Bryan Dirks, S. Stankovic, Maurizio Fava, Michael E. Thase, Sarah Atkinson, Mark Joyce, Tim Lin
article en
6 citations

Abstract

No abstract available for this paper.
Psychopharmacology BulletinVol. 52(4)
Acadia Pharmaceuticals (United States) (US), Atkins (United States) (US), Massachusetts General Hospital (US), CNS Healthcare (US), Philadelphia VA Medical Center (US), University of Pennsylvania (US)
Good health and well-being
Openalex Percentile: Top 19%
Tryptophan and brain disorders
1.73
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Adjunctive Pimavanserin in Patients with Major Depressive Disorder: Combined Results from Two Randomized, Double-Blind, Placebo-Controlled Phase 3 Studies — Becky Howell, Bryan Dirks, et al. · Psychopharmacology Bulletin (2025) | TGRS Research Map | TGRS